SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the Quarterly Period ended March 31, 1998
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Commission File Number: 33-18099-NY and 33-23169-NY
QUEST PRODUCTS CORPORATION
(Exact Name of small business issuer as specified in its charter)
DELAWARE 11-2873662
State or other jurisdiction of (IRS Employer I.D. No.)
Incorporation or organization)
6900 Jericho Turnpike, Syosset, New York 11791
(Address of principal executive offices)
Issuer's telephone number, including area code: (516) 364 - 3500
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) filed all reports required to
be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934, during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
YES _X_ NO ___
Indicate the number of shares outstanding of each of the issuer's classes of
Common Stock, as of the last practicable date.
Class Outstanding at March 31, 1998
- --------------------------- -----------------------------
Common Stock, par value 152,703,713
$.00003 per share
<PAGE>
PART 1 FINANCIAL INFORMATION
Item 1, financial statements
QUEST PRODUCTS CORPORATION
FINANCIAL STATEMENTS (Unaudited)
March 31, 1998
Financial Statements Page
Balance Sheet 3 - 4
Statements Operations 5
Statements of Shareholders' (Deficit) 6
Statements of Cash Flows 7 - 8
Notes to Financial Statements 9 - 10
Management's Discussion and Analysis 11 - 13
Other Information 14
Signatures 15
2
<PAGE>
QUEST PRODUCTS CORPORATION
Balance Sheet
March 31, 1998
(Unaudited)
Assets
Current Assets
Cash $ 67,241
Accounts receivable-net of allowance for doubtful
accounts of $1,000 58,351
Inventory 90,290
Prepaid expenses 1,496
--------
217,378
Furniture and Equipment - at cost - net of accumulated
depreciation of $20,019 28,396
Patents - at cost - net of accumulated amortization of
$10,547 38,888
Security Deposits 4,137
--------
$288,799
========
See notes to financial statements.
3
<PAGE>
QUEST PRODUCTS CORPORATION
Balance Sheet
March 31, 1998
(Unaudited)
Liabilities and Shareholders' (Deficit)
Current Liabilities
1992 convertible debentures - including accrued interest
of $6,150 $ 16,150
Shareholder's loan 180,114
Accounts payable 558,752
Accrued officer and director's compensation 224,493
Loans from directors 34,415
Accrued expenses 27,027
-----------
1,040,951
-----------
Shareholders' (Deficit)
Series A Convertible Preferred Stock - par value $.001-
authorized 600,000 shares - no shares issued and
outstanding
Series B Convertible Preferred Stock - par value $.001-
authorized 5,000,000 shares - no shares issued and
outstanding
Common Stock - par value $.00003 - authorized
200,000,000 shares - 152,703,713 shares issued and
outstanding 4,581
Capital in excess of par 3,506,171
Accumulated (deficit) (4,262,904)
-----------
(752,152)
-----------
$ 288,799
===========
See notes to financial statements.
4
<PAGE>
QUEST PRODUCTS CORPORATION
Statements of Operations
(Unaudited)
For the Three Months Ended
March 31,
------------------------------
1998 1997
------------- -------------
Sales - net $ 282,072 $ 102,960
Cost of Sales 49,325 41,147
------------- -------------
232,747 61,813
------------- -------------
Selling Expenses 171,071 21,615
General and Administrative Expenses 148,310 140,763
------------- -------------
319,381 162,378
------------- -------------
(Loss) Before Other Income (Expenses) (86,634) (100,565)
------------- -------------
Other Income (Expenses)
Interest income 7 2,233
Interest (expense) (4,162) (14,620)
------------- -------------
(4,155) (12,387)
------------- -------------
Net (Loss) $ (90,789) $ (112,952)
============= =============
(Loss) Per Share $ NIL $ NIL
============= =============
Weighted Average Number of Shares
Outstanding (to nearest 1,000,000) 123,000,000 90,000,000
============= =============
See notes to financial statements.
5
<PAGE>
QUEST PRODUCTS CORPORATION
Statement of Shareholders' (Deficit)
For the Three Months Ended March 31, 1998
(Unaudited)
<TABLE>
<CAPTION>
Number of
Common Stock Amount Capital in
Shares $.00003 Excess of Accumulated
(Post-split) Par Value Par Value Deficit
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Balance - December 31, 1997 138,083,713 $ 4,142 $ 3,360,410 $(4,172,115)
Proceeds from sale of stock 14,620,000 439 145,761 --
Net (Loss) -- -- -- (90,789)
----------- ----------- ----------- -----------
Balance- March 31, 1998 152,703,713 $ 4,581 $ 3,506,171 ($4,262,904)
=========== =========== =========== ===========
</TABLE>
See notes to financial statements.
6
<PAGE>
QUEST PRODUCTS CORPORATION
Statements of Cash Flows Page 1 of 2
(Unaudited)
For the Three Months Ended
March 31,
--------------------------
1998 1997
--------- ---------
Cash Flows from Operating Activities
Net (loss) $ (90,789) $(112,952)
Adjustments to reconcile net (loss) to net cash
(used for) operating activities:
Depreciation and amortization 1,449 1,405
Expenses paid through the issuance of
restricted common stock -- 8,750
Accrued interest 4,162 5,375
(Increase) decrease in:
Accounts receivable (55,638) 2,520
Inventories (21,829) 34,730
Advances to Automotive Marketing,Inc -- (3,280)
Deferred preoperating and developmental costs -- (7,779)
Increase (decrease) in:
Notes payable-vendor -- (20,940)
Accounts payable (25,226) (9,870)
Accrued officers' and directors' compensation 81,000 42,500
Taxes payable -- (1,898)
Loans from directors (1,400) 623
Accrued expenses 1,724 (18,045)
--------- ---------
(106,547) (78,861)
Cash Flows from Investing Activities
Patent payments -- (1,435)
--------- ---------
-- (1,435)
--------- ---------
Cash Flows from Financing Activities
Proceeds from sales of common stock 146,200 --
Repayments to shareholder -- (7,500)
--------- ---------
146,200 (7,500)
--------- ---------
Net Increase in Cash 39,653 (87,796)
Cash - beginning 27,588 260,372
--------- ---------
Cash - end $ 67,241 $ 172,576
========= =========
See notes to financial statements.
7
<PAGE>
QUEST PRODUCTS CORPORATION
Statements of Cash Flows Page 2 of 2
(Unaudited)
For the Three Months Ended
March 31
--------------------------
1998 1997
------------ -----------
Supplemental Disclosures
Interest paid $ -- $ --
=========== ===========
Temporary media funds received $ -- $ --
=========== ===========
See notes to financial statements.
8
<PAGE>
QUEST PRODUCTS CORPORATION
NOTES TO FINANCIAL STATEMENTS (Unaudited)
March 31, 1998
1. BACKGROUND AND BASIS OF PRESENTATION
Quest Products Corporation (the "Company") was organized as a Delaware
Corporation on July 17, 1987 and operated as a development stage company
through 1993. The Company's purpose is to market and distribute its
patented phase-out system smoking cessation device (the "product").
The Company had primarily marketed the product in the United States through
direct response marketing including radio, television spots and
infomercials. This domestic marketing was curtailed due to the ongoing
negotiations with the Federal Trade Commission ("FTC"), which have been
concluded. In March 1998, the Company reentered the domestic retail market.
The Company also distributes the product overseas.
The financial statements have been prepared assuming that the Company will
continue as a going concern. The Company has suffered recurring losses from
operations ($90,789 in 1998 and $112,952 in 1997), and has had limited
liquidity causing difficulty in meeting its current operating expense
obligations and debt service requirements. The Company is actively
marketing the product to help improve revenues and may seek additional
financing through private placement of debt and securities. The financial
statements do not include any adjustments that might result should the
continued existence of the Company be threatened by any continued losses or
the failure of the above factors to influence the financial viability of
the Company.
The interim statements were prepared pursuant to the requirements for
reporting on Form 10- QSB. The interim financial statements and notes
thereto should be read in conjunction with the financial statements and
notes included in the Company's latest Annual Report on Form 10-KSB for the
year ended December 31, 1997. In the opinion of management, the interim
financial statements reflect all adjustments of a normal recurring nature
necessary for a fair statement of the results for interim periods. The
current period results of operations are not necessarily indicative of the
results for the entire year ending December 31, 1998.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Changes in significant accounting policies - There were no changes in
significant accounting policies during the current period.
3. RELATED PARTY TRANSACTIONS
Loans from Director and Officer - A former officer/shareholder, who is
still a director of the Company, is owed $34,415 by the Company. The amount
is payable on demand with a stated interest rate of 11%. Effective June 30,
1997, the former officer/shareholder agreed to no longer charge interest.
9
<PAGE>
QUEST PRODUCTS CORPORATION
NOTES TO FINANCIAL STATEMENTS (Unaudited)
March 31, 1998
Officer's and Director's Compensation - During 1996, an investor group
brought in by two individuals which acquired an 18% ownership interest for
$500,000 was awarded two seats on the Board of Directors and one officer's
position. The two individuals had consulting agreements for which the
Company accrued fees of $5,000 per month for each individual from July 1996
through November 1997. In December 1997, the Company entered into
employment contracts with each of these two individuals for $150,000 per
year for five years from December 1997 through November 2002 and issued
options to purchase 7,500,000 shares each at an exercise price of $.03 per
share. As of March 31, 1998, the two individuals were owed $85,000 each in
accrued consulting fees and salaries.
A director, who was previously the Company's chief executive officer,
entered into a consulting agreement with the Company for $2,000 per month
from October 1997 through September 1998. As of March 31, 1998, he is owed
$54,493 in accrued salary, consulting fees and expenses.
4. SHAREHOLDER'S LOAN
During 1996, the Company received $200,000 from a shareholder as a loan in
connection with the Company's media campaign. Repayments of $35,000 were
made in cash and $7,500 in stock. The repayment of the $157,500 of
remaining principal at March 31, 1998 and $22,614 of interest which accrues
at 10% will be negotiated.
5. COMMITMENTS, CONTINGENCIES AND OTHER COMMENTS.
Dependence on Major Customers and Suppliers - Domestic retail sales
represent approximately 90% of sales with only one retail customer
representing more than 10% of total sales.
The Company is currently purchasing 100% of its products from two vendors.
Regulatory Matters - There have been no changes in the status of regulatory
inquiries by the Food and Drug Administration (FDA) and the Federal Trade
Commission (FTC).
Litigation - In July 1997, the Company's former attorney, who is a relative
of a Director, brought an action against the Company in New York State
Supreme Court, New York County for unpaid attorney fees and disbursements
of approximately $18,000. Legal counsel has not rendered an opinion as to
the ultimate outcome of this matter.
10
<PAGE>
QUEST PRODUCTS CORPORATION
Management's Discussion and Analysis
Results of Operations
Three Months Ended March 31, 1998 Compared
to Three Months Ended March 31, 1997
The Company incurred a net loss of $90,789 for the three months ended March
31, 1998 as compared to the loss of $112,952 for the three months ended March
31, 1997. Three-month sales increased $179,112. The increase in sales resulted
from a retail sales program which began in March 1998.
Selling expenses increased from $21,615 to $171,071 as a result of the
additional costs associated with the distribution of the product into retail
chain drug stores.
General and administrative expenses increased from $140,763 to $148,310 as
a result of an increase in officer salaries ($56,322) less a decrease in office
salaries and consulting fees ($45,247).
The gross profit margin increased from 60% to 82%, due to the high volume
of domestic retail sales.
The Company maintains a $1,000,000 liability insurance policy.
11
<PAGE>
QUEST PRODUCTS CORPORATION
Management's Discussion and Analysis
Liquidity and Capital Resources
Cash of $106,547 was used for operations for the 3 months ended March 31, 1998
as compared to $78,861 used in the same period of last year. Cash increased
during the 3 months ended March 31, 1998 by $39,653.
The Company's working capital has deteriorated due to the use of current assets
for operations. Working capital and current ratios were:
<TABLE>
<CAPTION>
March 31, December 31, March 31,
1998 1997 1997
---- ---- ----
<S> <C> <C> <C>
Working capital
(deficiency) $823,573 $880,433 $555,976
Current ratios 0.21:1 0.10:1 0.35:1
</TABLE>
In order to meet short-term marketing goals, in July 1997 certain officers and
directors agreed to acquire an aggregate of 10,000,000 shares of the Company's
common stock (representing 8% of total shares outstanding) for an aggregate
purchase price of $100,000. The Company is also seeking an additional $240,000
of financing under the same terms and conditions as offered to the officers and
directors. As of March 31, 1998, the Company has received $318,700. There is no
assurance that the Company will be able to obtain additional financing.
Distribution and Marketing
Marketing (Domestic)
In March 31, 1998, the Company entered the U.S. retail market under the
category of smoke cessation products.
Marketing (International)
On August 21, 1995, the Company entered into an agreement with a South
Korean trading company for the distribution and manufacture of a modified
(design) PhaseOut product in South Korea. Because of the improved design and
reduced size of this PhaseOut device, it will be utilized in the Japanese market
as well. South Korea has 10 million smokers and Japan has 35 million smokers.
Distribution in South Korea is expected to begin in the 3rd quarter of 1998.
12
<PAGE>
QUEST PRODUCTS CORPORATION
Management's Discussion and Analysis
New Products
In May 1997, the Company entered into a joint venture with Automotive
Marketing, Inc. to manufacture and distribute aftermarket automobile products.
As of March 31, 1998, the Company has incurred expenses of $130,716 with the
understanding that any such expenses will be reimbursed when revenue-producing
operations commence.
Regulatory Matters
There have been no material changes in the status of matters pending before
the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC).
13
<PAGE>
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
The Company has been sued by a former attorney for fees it alleges are
due but unpaid in the amount of approximately $18,000. Legal counsel
has not rendered an opinion as to the ultimate outcome of this matter.
Item 2. Changes in Securities
None
Item 3. Defaults Upon Senior Securities
None
Item 4. Submission of Matters to a Vote of Security Holders
None
Item 5. Other Information
See notes to the financial statements
Item 6. Exhibits and Reports
None
14
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
QUEST PRODUCTS CORPORATION
Dated: May 13, 1998
/S/:
------------------------------
Herbert M. Reichlin, President
15
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-END> MAR-31-1998
<CASH> 67,241
<SECURITIES> 0
<RECEIVABLES> 59,351
<ALLOWANCES> (1,000)
<INVENTORY> 90,290
<CURRENT-ASSETS> 217,378
<PP&E> 48,415
<DEPRECIATION> (20,019)
<TOTAL-ASSETS> 288,799
<CURRENT-LIABILITIES> 1,040,951
<BONDS> 0
0
0
<COMMON> 4,581
<OTHER-SE> (756,733)
<TOTAL-LIABILITY-AND-EQUITY> 288,799
<SALES> 282,072
<TOTAL-REVENUES> 282,079
<CGS> 49,325
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 319,381
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 4,162
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (90,789)
<EPS-PRIMARY> 0
<EPS-DILUTED> 0
</TABLE>
